High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Authors:
- 31 July 2009
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 34 (2) , 489-506
Abstract
During the last decade, high-throughput technologies including genomic, epigenomic, transcriptomic and proteomic have been applied to further our understanding of the molecular pathogenesis of this heterogeneous disease, and to develop strategies that aim to improve the management of patients with lung cancer. Ultimately, these approaches should lead to sensitive, specific and noninvasive methods for early diagnosis, and facilitate the prediction of response to therapy and outcome, as well as the identification of potential novel therapeutic targets.Genomic studies were the first to move this field forward by providing novel insights into the molecular biology of lung cancer and by generating candidate biomarkers of disease progression. Lung carcinogenesis is driven by genetic and epigenetic alterations that cause aberrant gene function; however, the challenge remains to pinpoint the key regulatory control mechanisms and to distinguish driver from passenger alterations that may have a small but additive effect on cancer development.Epigenetic regulation by DNA methylation and histone modifications modulate chromatin structure and, in turn, either activate or silence gene expression. Proteomic approaches critically complement these molecular studies, as the phenotype of a cancer cell is determined by proteins and cannot be predicted by genomics or transcriptomics alone.The present article focuses on the technological platforms available and some proposed clinical applications. We illustrate herein how the “-omics” have revolutionised our approach to lung cancer biology and hold promise for personalised management of lung cancer.Keywords
This publication has 183 references indexed in Scilit:
- The diploid genome sequence of an Asian individualNature, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingNature Genetics, 2008
- The complete genome of an individual by massively parallel DNA sequencingNature, 2008
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Nature Genetics, 2008
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Mutations of the BRAF gene in human cancerNature, 2002